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Abstract

An important step in building a multiple regression model is the selection of predictors. In genomic and epidemiologic studies, datasets with a small sample size
and a large number of predictors are common. In such settings, most standard
methods for identifying a good subset of predictors are unstable. Furthermore,
there is an increasing emphasis towards identification of interactions, which has
not been studied much in the statistical literature. We propose a method, called
BSI (Bayesian Selection of Interactions), for selecting predictors in a regression
setting when the number of predictors is considerably larger than the sample size
with a focus towards selecting interactions. Latent variables are used to infer
subset choices based on the posterior distribution. Inference about interactions
is implemented by a constraint on the latent variables. The posterior distribution
is computed using the Gibbs Sampling methods. The finite-sample properties of
the proposed method are assessed by simulation studies. We illustrate the BSI
method by analyzing data from a hypertension study involving Single Nucleotide
Polymorphisms (SNPs).
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A Bayesian method for finding
interactions in genomic studies
Abstract
An important step in building a multiple regression model is the selection of predictors. In genomic and epidemiologic studies, datasets with a small sample size
and a large number of predictors are common. In such settings, most standard
methods for identifying a good subset of predictors are unstable. Furthermore,
there is an increasing emphasis towards identification of interactions, which has
not been studied much in the statistical literature. In this article, we propose a
method, called BSI (Bayesian Selection of Interactions), for selecting predictors
in a regression setting when the number of predictors is considerably larger than
the sample size with a focus towards selecting interactions. Latent variables are
used to infer subset choices based on the posterior distribution. Inference about
interactions is implemented by a constraint on the latent variables. The posterior
distribution is computed using the Gibbs Sampling methods. The finite-sample
properties of the proposed method are assessed by simulation studies. We illustrate the proposed method by analyzing data from a hypertension study involving
Single Nucleotide Polymorphisms (SNPs).

Keywords: Bayesian variable selection; Conditional prior distribution; Constrained
Bayes inference; Gibbs sampling; Latent mixture modeling.
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1

Introduction
The selection of predictors is an important step in building a multiple regression

model. Given potential predictors, there are 2p possible regression models to consider.
When the number of potential predictors is larger than the number of samples, conventional methods will yield unstable predictor subsets. The limited sample size undermines
the ability to explore all the models. When interaction terms are to be considered as
well, identifying predictors becomes even more problematic.
In practice, this problem occurs frequently in genomic epidemiology studies ranging from high throughput microarray experiments to high-density genome scans. Furthermore, the complexity of common diseases motivates more comprehensive studies
involving gene-gene interactions, gene-environment, and gene-risk factor interactions.
As an example, we consider hypertension. It is well-known that hypertension is the
consequence of interactions among many genetic and environmental factors. As part of
the Genetic Epidemiology Network of Atherosclerosis (GENOA) study, a large number
of single nucleotide polymorphisms (SNPs) were typed in individuals with and without hypertension. Some SNPs were found to be associated with hypertension-related
traits when considered univariately (Barkley et al. , 2004). In our paper, we extend
this research to examine the impact of SNPs, risk factors, and their SNP-risk factors
interactions on age of hypertension onset in the non-Hispanic white population. The 57
SNPs from 15 genes on chromosome 2 and 9 risk factors in 342 unrelated individuals
were selected from the GENOA study. Therefore, the potential predictors in this analysis consist of 123 main effects (114 dummy variables + 9 risk factors) and 1149 SNP-risk
factor interaction terms. Traditional variable selection procedures cannot identify susceptible SNP-risk factor interactions in this situation.
The identification of the predictors in the “large p small n” (West, 2000) setting
2
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has motivated a considerable amount of statistical research in recent years. Univariate
(individual gene) selection procedures are fairly common, such as those in Rosenwald et
al. (2002) and Beer et al. (2002). Such procedures must deal with the inherent multiple
testing issue, which may be avoided by reducing the dimension of the data. For example,
West (2000) applied the singular-value decomposition to the design matrix to reduce the
dimension of the problem in the Bayesian framework.
A Bayesian procedure for variable selection, the Stochastic Search Variable Selection
(SSVS), was proposed by George and McCullough (1993, 1997). It entails the specification of a hierarchical latent mixture prior and uses the posterior probabilities to
identify the more promising models. Lee et al. (2003) applied the SSVS method to the
problem of gene selection with microarray data. Similarly, Sha et al. (2004) utilized
the multivariate Bayesian variable selection method of Brown et al. (1998a, 1998b) to
the classifications of microarray data. These methods all focus on the issue of selecting
main effects. While some recent scientific research has focused on the importance of the
interactions in genetic studies (Longmate 2001; Culverhouse et al. , 2002; Devlin et al. ,
2003), identification of interactions has not been studied much in the statistic literature.
This paper addresses the issue of variable selection, primarily that of interactions
selection, when the number of variables greatly exceeds the sample size. We propose a
new method called Bayesian Selection of Interactions (BSI). It extends the framework
in SSVS and introduces novel priors for interactions. Section 2 specifies the model and
describes the prior distributions. In Section 3, we discuss how to implement it using
Gibbs sampling (Gelfand and Smith, 1990). Identification of candidate sets of variables
is discussed in Section 4. The performance of BSI is assessed using simulation studies in
Section 5. In Section 6, BSI is applied to the previously described hypertension study.
We conclude with some discussion in Section 7.

3
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Bayesian variable selection framework

2
2.1

Normal mixture model

We start with a linear regression model with normal errors:
Y |β, σ ∼ Nn (Xβ, σ 2 In ),
where Y is an n-vector of response, Nn an n-dimensional multivariate normal distribution, X an n × p design matrix of predictors, β a p-vector of regression coefficients, σ 2
a scalar, and In an n × n identity matrix. The central concept of the SSVS method
is to introduce γ , a p-vector of binary latent variable with components γ1 , . . . γp . It
represents the importance of the corresponding regressors. For j = 1, . . . p, if γj = 1
then Xj is included in the model. If γj = 0 then Xj is excluded from the model. A
mixture normal prior for the coefficients β is conditioned on γ:
βj |γj ∼ (1 − γj )N1 (0, τj2 ) + γj N1 (0, c2j τj2 )

(1)

In a matrix form, (1) can be written as: β|γ ∼ Np (0, Dγ2 ), where Dγ is a p × p diagonal
matrix with the j th diagonal element equal to (1−γj )τj +γj cj τj . For simplicity, the prior
distribution assumes the components of β are a priori independent. Then the variable
selection problem is to make inferences regarding γ.
The choice of appropriate values of τj and cj is important. The recommendations
for choosing τj and cj are outlined by George and McCulloch (1997). The key point is
to introduce a “practical significance” δ . If |βj | < δj then γj = 0 and Xj would be
excluded. That is, δj is the intersection point of the densities of N (0, τj2 ) and N (0, c2j τj2 ).
A value of cj determines the magnitude of the difference between the two mixture normal
distributions. Empirical evidence (George and McCulloch, 1997) has shown that cj
between 10 and 100 leads to an efficient computation. For a given δj and cj , τj is
4
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δj . Note that the non-conjugate prior
then obtained as τj ≡ 2c2j log(cj )/(c2j − 1)
distribution (1) of β does not depend on the unknown value of σ, so τj does not depend
on σ. When a “practical significance” δj cannot be meaningfully specified, one might
consider:
βj |γj ∼ (1 − γj )I0 + γj N1 (0, τj2 ),
where I0 is a point mass at 0. For this choice, δj ≡ 0 corresponding to the preference
that any βj 6= 0 be included in the model. This is the setup considered by Geweke
(1996), and Brown et al. (1998a, 1998b).
Similar to ridge regression, τj and cj will determine the degree of shrinkage for the
coefficients β through the posterior distributions. This shrinkage effect allows BSI to
handle the “large p small n” problem.
A conjugate Inverse Gamma prior is chosen for the residual variance σ 2 :
σ 2 ∼ IG(ν/2, νλ/2).
This prior can be thought of as an additional likelihood from a dataset with sample
size ν and sample variance λ. In the absence of prior information, we suggest using an
uninformative prior by taking ν and λ close to zero.

2.2
2.2.1

Prior specification of γ in BSI
Prior choice for γ without interactions

We expect that only a small portion of candidates are associated with the outcome in
most high-throughput studies. Based on this prior knowledge, larger weights should be
assigned to more parsimonious models. This can be implemented via either of the two
different prior distributions for γ , which we call the Beta-Bernoulli and Beta-Binomial
prior.
5
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The Beta-Bernoulli prior is defined as follows:
γj |πj ∼ Bernoulli(πj ),
πj

∼

Beta(a, b).

This prior allows each γj to have a different prior probability πj , and γi and γj are a
priori independent for i 6= j. If all the πj are same (πj ≡ π for j = 1, . . . , p), we call
this the Beta-Binomial prior. This specification assumes a priori marginal dependency
between γi and γj . The covariance of γi and γj is equal to the variance of the Beta
distribution.
To favor parsimonious models, hyperparameters (a, b) of the Beta distribution can
be chosen to force π to be small. For example, by specifying the mean and mode for
the Beta distribution and solving for (a, b) we obtain
a=

mean − 2 × mode × mean
(1 − 2 × mode) × (1 − mean)
, b=
mean-mode
mean-mode

Intuitively, the mode is the most likely proportion of all potential predictors to be
selected in the model. The mean corresponds to the expected proportion of all potential
predictors to be included in the model. The difference of mean and mode controls the
variation in the prior distribution. The smaller the difference, the more informative is
the prior distribution. For example, if our initial guess that the most likely number
of selected predictors is 10 for a dataset with 1000 potential predictors, we specify the
mode as 10/1000. If we specify the mean as 12/1000 (20% larger than the mode), then
the values of the parameters (a, b) are (5.88,484.12). The sensitivities with respect to
the choice of parameters (a, b) are assessed in the simulation studies described in Section
5.

6
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2.2.2

Prior choice for γ with interactions

In some studies, the interactions are of interest as well. We adopt the convention
that a model containing an interaction term should also contain the corresponding main
effects (Neter et al., 1996), since the interaction represents a deviation from an additive
model. The previously specified prior distribution for γ can be adjusted to manifest this
convention.
Without loss of generality, suppose that there are three main effects A, B and C. Let
the corresponding latent variables for the main effects and the pair-wise interactions
be (γA , γB , γC ) and (γAB , γAC , γBC ), respectively. The joint prior can be factored by
assuming that (γAB , γAC , γBC ) are independent given π, and (γA , γB , γC ) are independent
given all the interactions and π:
p(γA , γB , γC , γAB , γAC , γBC |π)
= p(γAB , γAC , γBC |π)p(γA , γB , γC |γAB , γAC , γBC , π)
= p(γAB |π)p(γAC |π)p(γBC |π)·
p(γA |γAB , γAC , γBC , π)p(γB |γAB , γAC , γBC , π)p(γC |γAB , γAC , γBC , π).
This can be further simplified by assuming that the importance of the main effect only
depends on the importance of its interaction terms. That is γA depends on (γAB , γAC , π)
but not γBC . Thus, the joint prior is
p(γA , γB , γC , γAB , γAC , γBC |π)
(2)

= p(γAB |π)p(γAC |π)p(γBC |π)
· (γA |γAB , γAC , π)p(γB |γAB , γBC , π)p(γC |γAC , γBC , π).

These two assumptions correspond to the commonly used principles for variable selection. The dependence between the main effect and the interactions is defined by the

7
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components of joint prior (2). For example:

 1 if max(γAB , γAC ) = 1
p(γA = 1|γAB , γAC , π) =
 π if max(γ , γ ) = 0
AB
AC
p(γAB = 1) = p(γAC = 1) = π

(3)

π ∼ Beta(a, b)
We call this the Conditional-Beta-Binomial prior distribution. If π is different for each
main and interaction term, we call this the Conditional-Beta-Bernoulli prior. This prior
specification reduces the model space greatly. Note that the unconditional prior is a
special case of the conditional prior when there is no interaction term.

3

Gibbs sampling algorithm
When the number of predictors p is large, it is impractical to exhaustively evaluate

the posterior probabilities for 2p models. Indeed, most of the models have a very small
probability and will appear very rarely. These models can be ignored. We use a Gibbs
sampling algorithm to estimate the posterior distribution as used in SSVS focuing on
the models that have high probabilities.
The Gibbs sampler simulates a Markov chain β (1) , σ (1) , γ (1) , π (1) , β (2) , σ (2) , γ (2) , π (2) , . . .
from the full conditionals which converge to the joint posterior p(β, σ, γ, π|Y ) (Gelfand
and smith, 1990). It can be shown that the full conditional distributions for β and σ 2
are normal and inverse Gamma, respectively. Their density functions are:
p(β|σ 2 , γ, π, Y ) = p(β|σ 2 , γ, Y )
= Np ((X T X + σ 2 Dγ−2 )−1 X T Y, σ 2 (X T X + σ 2 Dγ−2 )−1 )
p(σ 2 |β, γ, π, Y ) = p(σ 2 |β, Y )
¶
µ
n + ν |Y − Xβ|2 + νλ
,
.
= IG
2
2
8

Hosted by The Berkeley Electronic Press

Using Bayes rule, the full conditional distribution of γ using conditional-Beta-Binomial
prior is Bernoulli with probability
p(γj = 1|β, σ 2 , γ−j , Y, π) = p(γj = 1|β, γ−j , π)
p(γj = 1, β, γ−j , π)
p(γj = 1, β, γ−j , π) + p(γj = 0, β, γ−j , π)

=

where γ−j is a vector of the elements of γ except for the j th element . Define a p-vector
of indicator variables ξ ≡ (ξ1 , . . . , ξp ) as ξj = 0 if an interaction, and ξj = 1 if a main
effect, j = 1, . . . , p. Let Ωj denote the set that includes all the interactions related to the
j th main effect, and thus the full conditional distribution of γ is as follows (see Appendix
for the derivation):
p(γj = 1|β, σ 2 , γ−j , Y, π)

p(βj |γj =1)π

p(βj |γj =1)π+p(βj |γj =0)(1−π)
=
 1

P
when ξj = 0 or ξj = 1 and
γj 0 ∈Ωj γj 0 = 0
P
when ξj = 1 and
γj 0 ∈Ωj γj 0 > 0.

Note that the final equation is a simple form given the independent prior for β in (1).
The full conditional distribution for γ using Conditional-Beta-Bernoulli prior is:
p(γj = 1|β, σ 2 , γ−j , Y, πj )

p(βj |γj =1)π

p(βj |γj =1)πj +p(βj |γj =0)(1−πj )
=
 1

P
when ξj = 0 or ξj = 1 and
γj 0 ∈Ωj γj 0 = 0
P
when ξj = 1 and
γj 0 ∈Ωj γj 0 > 0.

The derivation is similar and thus omitted.
The full conditional distribution for π using Conditional-Beta-Binomial prior is:
2

π|β, σ , γ, Y ∼ Beta(a +

p
X
j=1

where q ≡

Pp

P
j=1 I{ γj 0 ∈Ωj γj 0 >0, ξj =1}

γj − q, p −

p
X

γj + b),

j=1

is the number of main effects that are forced to be

in the model due to the interactions (See the Appendix for the derivation). Note that
the first scale parameter of this Beta distribution is reduced by a quantity of q, since
9
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some main effects do not provide any information on π as in (3). Similarly, the full
conditional distribution for πj using Conditional-Beta-Bernoulli is
³
πj |β, σ 2 , γ, Y ∼ Beta a + γj − I{Pγ 0 ∈Ω
j

j

γj 0 >0, ξj =1} ,

´
1 − γj + b

These conditionals are standard distributions which can be simulated by routine
methods. When p is large, the number of possible models 2p in the model space often
far exceeds the number of iterations of the Gibbs sampler. The convergence rate and
criteria of the MCMC algorithm become a critical issue. The correlation structure of
a design matrix can have a great impact on the convergence rate of MCMC methods
(Geweke, 1996). Making the explanatory variables orthogonal to each other can strongly
improve convergence and mixing (Clyde et al. 1996, Gelfand et al. 1995). Therefore, we
standardize each variable in the data set before we start the variable selection procedure.
There is much literature regarding convergence criteria of Markov Chain Monte Carlo
algorithms. A good review can be found in Mengersen et al. (1999). We use Rubin’s
R (Gelman et al., 1995), between and within sequence variance, to monitor the conP
vergence for each scalar estimate, such as σ and pj=1 γj . Ten independent sequences
were simulated simultaneously with starting points drawn from the overdispersed distributions. For example, for the initial value of β, ridge regression estimates were used,
given different shrinkage values. The shrinkage values are between zero and the smallest
eigenvalue of the matrix X T X . Here X is the design matrix.

4

Selection of predictors
Selecting the predictors under the joint posterior distribution is commonly used in

a Bayesian framework. However, when the number of predictors greatly exceeds the
sample size, the prior has a substantial impact on the posterior distribution. A joint
10
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prior distribution p(γ) which favors the models with few or no predictors leads the
posterior to favor such models. This property is observed in a simulation study as well
(data not shown). Furthermore, the model space is extremely large when p is large.
Most models will only appear once in the stochastic process.
A simple illustration of the prior probability of γ through a simple example with 2
main effects and 1 interaction is shown in Table 1. Under the unconditional prior, the
model space consists of 8 possible combinations. As stated in Section 2, Table 1 shows
that the model space is smaller when we impose the constraint due to the interactions.
We let w = a(a + b)−1 be the mean of the Beta distribution. The smaller the w, the
bigger the joint probability p(γ) of the null model. The null model is defined as no
variable selected. If we set w = 0.01, then the prior odds ratio of the null model to
a one variable selected model is (1 − w)/w = 99, to a two variables selected model is
(1 − w)2 /w2 = 9801. This weighting scheme leads to the more parsimonious models.
While the joint prior probability varies according to the number of regressors in the
model, the marginal prior probabilities are invariant. Under the unconditional prior,
the p(γj ) are the same. Under the conditional prior, the the p(γj ) of the main effects
are higher but still identical to each other, and that of the interactions are same as
before. Extending this result, the marginal prior probability of a main effect selected is
1−(1−w)ν+1 and that of an interaction term is w, where ν is the number of interactions
that related to the main effect in question. As ν increases, the marginal prior probability
for that main effect increases. If only two-way pair-wise interactions are considered, then
ν =p−1 .
We select the important predictors based on marginal posterior probabilities P (γj |Y ),
which is estimated by the occurrence of selection of a variable across the iterations of
the Markov Chain. The resulting list of predictors is referred to as an importance list.
However, a model with all the important predictors selected by the marginal posterior
11
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probabilities may never appear in the iterations of Gibbs sampling. For prediction purposes, it is desirable to select under the joint posterior probability. In this case, we
propose a two-stage selection method. Stage I is for the variable selection. We perform
BSI on all the potential predictors and rank the predictors according to the estimated
P (γj |Y ). The top k interactions including the main effects are selected based on this
quantity. (Section 5 discuss the guidelines for choosing k). Stage II is for one model
selection or model averaging. BSI is conducted again on the selected terms, but we
rank the models according to the estimated P (γ|Y ). If one model is preferred in prediction, we select the model with the highest posterior probability. If model averaging
is preferred, we keep all the visited distinctive models or a subset of models with high
posterior probabilities.

5

Simulation study
In this section, we evaluate the BSI through simulation studies. First, we compare

the performance of the Beta-Bernoulli prior versus the Beta-Binomial prior when interactions are not considered. Second, we compare the performance of the ConditionalBeta-Binomial versus the Beta-Binomial when interactions are considered. For each
comparison, the sensitivity of the hyperparameters is also studied.
Some factors that may affect the performance of the BSI are considered during
the study design, such as the possible sample circumstances, the method’s underlying
assumptions, and the choice of parameters in the hyperprior. For simplicity, we restricted
our attention to four factors: the correlation coefficient ρ among the potential predictors,
the prior distributions for γ , the hyperparameters of the Beta distribution, and the
cutoff value k in Stage I.
We constructed a sample of size n = 20 on p = 50 potential predictors by gen12
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1/2

erating z, z1 , . . . , z50 i.i.d. ∼ N20 (0, I20 ) and setting Xj = zj + z (ρ(1 − ρ)−1 )

for

j = 1, . . . , 50. This produced a pair-wise correlation of ρ among X1 , . . . , Xp , and
ρ = (0.1, 0.3, 0.5, 0.7, 0.9). We drew Y ∼ N20 (X1 + 1.5X2 + 3X3 , σ 2 I20 )where σ = 1.
For each value of ρ, we fixed the simulation replications at 250. Two prior distributions were used for γ: the Beta-Bernoulli prior and the Beta-Binomial prior. For the
hyperprior Beta distribution, two sets of the (mode, mean) were used: (0.1, 0.12) and
(0.2, 0.22). At Stage I, we used different cutoff values k = (2, 4, 6, 8, 10, 12, 14) to obtain
subsets resulting from the rank of the P (γj |Y ).
The true and false positive rates of identifying the true predictors for various choices
of k were calculated. Receiver Operating Characteristic (ROC) curves were constructed
by plotting the true positive rate (sensitivity) against the false positive rate ( 1- specificity) for the different possible cut off values. The area under the curve measures how
well the method separates the true predictors and noise. In Figure 1(a), we provide
the ROC curves of sensitivity analysis of prior distribution: Beta-Bernoulli vs. BetaBinomial. The sensitivity analysis of the choice of the hyperparameters (mode, mean)
for Beta distribution is shown in Figure 1(b).
Both figures show the choice of the prior distribution or the parameters in hyperprior (even when we double the value of the mode) is not sensitive in our method.
Furthermore, an analysis of variance (ANOVA) test of four factors shows that the prior
distribution and parameters in hyperprior are not significant factors in terms of the true
positive rates (See Table 2).
As we expected, the higher the correlation among the potential predictors, the lower
the true positive rates. If high collinearity exists in the data, the selection of predictors
will be affected by the ‘dilution’ effect (George, 1999). This happens because the correlated predictors change the relative marginal posterior probability allocation to those
predictors. The sensitivity is also highly associated with cutoff value k. The higher the
13
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cutoff value k, the higher the true positive rate. The simulations presented in this paper
have the ratio of p/n equal to about 2.5. Higher ratios are studied for the power of BSI.
According to the empirical study we suggest a cutoff range for k, 3× mode ×p ≤ k < n.
The mode is the initial guess of the most likely proportion of all potential predictors to
be selected in the model. If the ratio of p/n is larger than 10, select k close to n.
We proceeded to evaluate the proposed conditional prior for variable selection with
interaction terms. A sample of size n = 20 on 10 main effects and 45 pair-wise interaction
terms was generated. We induced a pair-wise correlation of ρ = (0.1, 0.3, 0.5, 0.7, 0.9)
among the main effects in the same manner as in the previous sample. We drew
Y ∼ N20 (X1 + X2 + X3 + X4 + X1 X2 + X1 X4 , σ 2 I20 ), where σ = 1. Again, for each
value of ρ, we fixed the simulation replications at 250. Two prior distributions were
used for γ: Conditional-Beta-Binomial and Unconditional-Beta-Binomial. For the beta
distribution, the (mode,mean) were set at (0.12, 0.14). We ran the Stage I variable
selection. For the main effects (Figure 2(a)) and the interaction terms (Figure 2(b)),
the proposed conditional priors always perform better than the unconditional prior in
terms of the true positive rate. The inclusion of the main effects whenever a related
interaction term is selected helps to identify the interaction term itself.
Different from the previous result for the main effects only simulation, an interesting
fact that we observed here is that high multicollinearity among the main effects helps in
the identification of the true predictors. For example, when the main effects A and B are
highly correlated, in part due to the surrogate effect of B, A and B both help identifying
the important interaction term, say AC. Therefore, there is a higher probability of
selecting AC. We also observed this phenomena in other simulation studies.

14
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6

Analysis of Hypertension Data
A detailed description of the GENOA sampling design and strategy are presented

elsewhere (O’Meara et al., submitted). The data consists of 342 unrelated, hypertensive
non-Hispanic white individuals from the Mayo Clinic field center of the GENOA study
who had complete SNP and risk factor data. The 57 SNPs (Table 3) were from 15 genes
on chromosome 2 where there had been previous linkage evidence of genes for hypertension (Province et al., 2003). The hypertension risk factors included in our study are age
(yrs), weight (kg), height (cm), BMI (kg/m2), family history of hypertension, fasting
plasma cholesterol (mg/dl), fasting plasma triglycerides (mg/dl), systolic blood pressure
(mmHg), and diastolic blood pressure (mmHg). Even though the BMI is correlated to
weight and height, we still include all of them and rely on the BSI method to select the
important effects and build a prediction model.
In this section, we illustrate the application of proposed method to the selection of
predictors for hypertension age of onset. Since each SNP is trichotomous by the nature
of the genotype, we code each of them into 2 dummy variables. Adopting the convention
of “all include” or “all exclude” (Neter et al., 1996), we assign a single latent variable
γj to a group of dummy variables. That is a many-to-one mapping (Chipman, 1996)
from the vector of regression coefficients to the vector of latent variables. This strategy
greatly reduces the model space in this data. Furthermore, Chipman (1996) discussed
that when a large group of variables is not important in terms of prediction, the chances
are large that one variable will appear important because of random variation. By only
considering the importance of the group instead of each variable in that group, the
chances of making such an error are reduced.
Only the SNP-risk factor interactions were considered in our hypertension data.
SNP-SNP interactions were not included because rarely do we have all combinations of
15
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genotypes from the data. For example, a 3 by 3 frequency table for any SNP pair often
shows that we have zero count in some allele combinations. This scenario is common
due to linkage disequilibrium (LD) and the rare relative allele frequencies.
To obtain the prior knowledge of the hyperparameters for the Beta distribution, we
used classical two-stage stepwise selection to identify the possible number of predictors.
Briefly, in stage one, we used stepwise selection to identify the main effects. In stage two,
we used the stepwise selection again on all the selected main effects and their SNP-risk
factor interactions, forcing the main effects to be included in the model. The selected
predictors showed in Table 5. Among 579 possible predictors, we have 7 predictors
chosen by the stepwise selection method. The ratio is about 0.012.
The two-stage stepwise method was chosen for the study purely for its simplicity in
implementation. However, it has disadvantages besides the well-known problem of the F
statistics. First, if the number of main effects to start with already exceeds the number
of samples, we cannot obtain a reasonable model without specifying a maximum number
of terms included. The selection of a maximum number of terms could be subjective
without cross-validation, which is computationally intensive. Second, SNPs without
strong association with the outcome will be eliminated in the first stage. Therefore,
some SNPs which may contribute through the SNP-risk factor interaction will not be
considered in the second stage.
We next performed Stage I of the selection procedure. The Conditional-Beta-Bionomial
prior was chosen for the latent variable γ. The mode and mean of the Beta prior were
P
set at (0.012, 0.018) according to the previous discussion. The trace of σ 2 and 579
j=1 γj
from 10 independent chains are shown in Figure 3(a) and Figure 3(b), respectively.
Figure 4 shows the marginal posterior distributions of γ for 579 regressors. The
spike in the graph corresponds to age, which makes sense. The age would be expected
to be highly correlated to the age of onset of hypertension. We ranked the P (γj |Y ) at
16
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Stage I. Table 4 shows the top 20 main effects and the top 5 interaction terms associated
with hypertension. It is plausible that multiple hypertension genes are located in the
region examined. Thus, the present findings are suggestive and should be validated with
follow-up studies.
To find the “best” prediction model, we proceeded to the Stage II selection using the
main effects and the interactions in Table 4. The mode and mean of the Beta prior at
Stage II were set at (0.45, 0.50), which defines a uniform distribution for the probability
of γj = 1, where j = 1, . . . , 25. Table 5 shows the top 3 ranked models selected by Stage
II. Our preliminary analysis identified a “best” model with 2 risk factors: age and strong
family history; two SNPs: AUP1 cv11727841 and SLC20A1 CV9546434; and one interaction term: strong family history × AUP1 cv11727841. Its estimated coefficients
and p-value are showed in Table6. Age, SLC20A1 CV9546434, AUP1 cv11727841, and
strong family history × AUP1 cv11727841 reached the statistical significance for age of
hypertension onset.
SLC20A1 is a sodium-dependent phosphate transporter with expression across tissues, including the kidney. The protein encoded by AUP1 has been shown to bind to
the conserved membrane-proximal sequence of the cytoplasmic tail of integrin alpha(IIb)
subunits. These subunits play a crucial role in the integrin alpha(IIb) beta(3) inside-out
signaling (http : //www.ncbi.nlm.nih.gov). Future studies should attempt to replicate
these findings in other populations. The adjusted R-square of this model is 0.3161, which
is similar to 0.3191 from a model selected by stepwise selection method (See Table5).
We notice that BSI method achieves comparable predictive accuracy through a more
parsimonious model.
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7

Discussion
BSI is quite general and can be applied in many variable selection or model building

problems, especially the challenging problems such as limited sample size and related
predictors. The same idea of constructing the prior for interactions can be extended to
exploring the functional terms of predictors. For example, the lower order polynomials
are included if a higher order one is selected. BSI also can be applied in a variety
of scientific disciplines. For instance, it can be applied in the epistasis (the interaction
between two or more genes to control a single phenotype) in genetic study, the interaction
effects of the biomarkers in pharmacogenomic study, and the gene selections in highthroughput microarray analysis.
To force the inclusion of the main effects when the interaction term is selected, we
imposed a constraint on γ. An alternative method is to impose constraints on β. The
general idea is that if a predictor is important, the magnitude of its coefficient is large.
Consider the same example with 3 main effects in section 2.2.2. Mathematically this is
accomplished by modifying the equation (1) to:
p(βA |γj ) = (1 − γA )(1 − γAB )(1 − γAC )N (0, τA2 )
+ [1 − (1 − γA )(1 − γAB )(1 − γAC )] N (0, c2A τA2 )
Since our primary interest is in the posterior distribution of γ, we chose imposing constraints directly on γ due to its computational efficiency using MCMC.
To select a “best” model, we proposed a two-stage selection. If a subset of important
predictors is desired instead of a predictive model, the importance list provided by stage
I selection is sufficient.
Although variable selection in the linear regression model is discussed in this paper,
we expect that the method can be extended to handle the generalized linear model
(McCullagh and Nelder, 1989) or proportional hazard model (Cox, 1972). For example,
18
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using the idea of data augmentation(Tanner and Wong, 1987), the probit regression
model for binary outcomes has an underlying normal regression structure on latent
continuous data. The method can also be generalized to multinomial response models
with more than 2 categories (Albert and Chib, 1993). This data augmentation can also
be used in proportional hazard model for censored survival times. We are currently
exploring this area.
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Appendix
.1

Full conditional distribution of γ using conditional-BetaBinomial prior
Using Bayes’ rule, the full conditional distribution of γ is Bernoulli
p(γj = 1|β, σ 2 , γ−j , Y, π) = p(γj = 1|β, γ−j , π)
=

p(γj = 1, β, γ−j , π)
,
p(γj = 1, β, γ−j , π) + p(γj = 0, β, γ−j , π)

where γ−j is a vector of the elements of γ except for the j th element γj . Let U ≡ p(γj =
1, β, γ−j , π), we have
U = p(γj = 1, β, γ−j , π)
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= p(β|γj = 1, γ−j , π)p(γj = 1, γ−j |π)p(π)
= p(βj |γj = 1)p(β−j |γ−j )p(γj = 1|γ−j , π)p(γ−j |π)p(π).
Let V ≡ p(γj = 0, β, γ−j , π), we have
V = p(βj |γj = 0)p(β−j |γ−j )p(γj = 0|γ−j , π)p(γ−j |π).
Define a p-vector of indicator variables ξ ≡ (ξ1 , . . . , ξp ) as ξj = 0 if an interaction, and
ξj = 1 if a main effect, j = 1, . . . , p. Let Ωj be the set that includes all the interactions
related to the j th main effect. Substituting U and V back into the full conditional
distribution and simplifying the equation, we have
U
p(γj = 1|β, σ 2 , γ−j , Y, π) = U +V
p(βj |γj = 1)p(γj = 1|γ−j , π)
=
p(βj |γj = 1)p(γj = 1|γ−j , π) + p(βj |γj = 0)p(γj = 0|γ−j , π)

p(βj |γj = 1)π

=
p(βj |γj = 1)π


=

.2



1−I{Pγ

j 0 ∈Ωj

γj 0 >0, ξj =1}

p(βj |γj =1)π
p(βj |γj =1)π+p(βj |γj =0)(1−π)

1

1−I{Pγ

j 0 ∈Ωj

γj 0 >0, ξj =1}

+ p(βj |γj = 0)π

1−I{Pγ

j 0 ∈Ωj

γj 0 >0, ξj =1}

P
when ξj = 0 or ξj = 1 and
γj 0 ∈Ωj γj 0 = 0
P
when ξj = 1 and
γj 0 ∈Ωj γj 0 > 0

Full conditional distribution for π using conditional-BetaBinomial prior
The derivation of the full conditional distribution for π follows from the following

fact. If IA and IB are two binary indicator variables, x is any real number, and IB = 1
¢1−IB
¡
= (1 − x)(1−IA )(1−IB ) . The proof of this fact is
when IA = 1, then 1 − x1−IA
straightforward and is omitted.
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The full conditional distribution for π is
p(π|β, σ 2 , γ, Y ) = p(π|γ)
∝ p(γ|π)p(π)
p ³
Y
1−I{Pγ ∈Ω γ 0 >0,
j j
j0
∝
π
j=1

=

p
Y

π


1−I{Pγ

j=1
Pp

=π

j=1

j 0 ∈Ωj

P
γj − pj=1 I{Pγ

= Beta(a +

p
X
j=1

where q ≡

γj 0 >0,

Pp

j 0 ∈Ωj

ξj =1}

´γj ³
1−I{Pγ ∈Ω γ 0 >0,
j j
j0
1−π


ξj =1} γj


1−I{Pγ

(1 − π)

γj 0 >0, ξj =1}

γj − q, p −

p
X

j 0 ∈Ωj

Pp

(1 − π)p−

j=1

γj

ξj =1}

γj 0 >0,

´1−γj ¡

π a−1 (1 − π)b−1


ξj =1} (1−γj )

¢

¡ a−1
¢
π (1 − π)b−1

¡ a−1
¢
π (1 − π)b−1

γj + b),

j=1

P
j=1 I{ γj 0 ∈Ωj γj 0 >0, ξj =1}

is the number of main effects that are forced to be

in the model due to the interactions.

References
[1] Albert, J.H., and Chib, S. (1993). Bayesian analysis of binary and polychotomous
response data. Journal of the American Statistical Association 88, 669-679.
[2] Barkley, R.A., Chakravarti, A., Cooper, R.S., Ellison, R.C., Hunt, S., Province,
M.A., Turner, S.T., Weder, A. B., and Boerwinkle, E. (2004). Positional identification of hypertension susceptibility genes on chromosome 2. Hypertension 43,
477-482.
[3] Beer, D.G., Kardia, S.L., Huang, C.C., Giordano, T.J., Levin, A.M., Misek,
D.E., Lin, L., Chen, G., Gharib, T.G., Thomas, D.G., Lizyness, M.L., Kuick,
R., Hayasaka, S., Taylor, J.M., Iannettoni, M.D., Orringer, M.B., and Hanash, S.
(2002). Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Medicine 8, 816-824.
21

http://biostats.bepress.com/umichbiostat/paper48

[4] Brown, P.J., Vannucci, M., and Fearn, T. (1998a). Multivariate Bayesian variable
selection and prediction. Journal of the Royal Statistical Society, Series B 60, 627641.
[5] Brown, P.J., Vannucci, M., and Fearn, T. (1998b). Bayesian wavelength selection
in multicomponent analysis. J. of Chemometrics 12, 173-182.
[6] Chipman, H. (1996). Bayesian variable selection with related predictors. The Canadian Journal of Statistics 24, 17-36.
[7] Clyde, M., DeSimone, H., and Parmigiani, G. (1996). Prediction via orthogonalized
model mixing. Journal of the American Statistical Association 91, 1197-1208.
[8] Cox, D.R. (1972). Regression Models and Life Tables. Journal of the Royal Statistical Society, Series B 34, 187-220.
[9] Culverhouse, R., Suarez, B.K., Lin, J., and Reich, T. (2002). A perspective on
epistasis: limits of models displaying no main effect. Am J Hum Genet 70, 461471.
[10] Devlin, B., Roeder, K., and Wasserman L. (2003). Analysis of multilocus models
of association. Genetic Epidemiology 25, 36-47.
[11] Gelfand, A.E., Sahu, S., and Carlin, B.P. (1995). Efficient parameterization for
normal linear mixed effects models. Biometrika 82, 479-488.
[12] Gelfand, A.E., and Smith, A.F.M. (1990). Sampling based approaches to calculating
marginal densities. Journal of the American Statistical Association, 85, 398-409.
[13] Gelman, A. B., Carlin J.S., Stern H. S., and Rubin D. B. (1995). Bayesian Data
Analysis. Chapman & Hall.
22

Hosted by The Berkeley Electronic Press

[14] George, E.I., and McCulloch, R.E. (1993). Variable selection via Gibbs sampling.
Journal of the American Statistical Association 88, 881-889.
[15] George, E.I., and McCulloch, R.E. (1997). Approaches for Bayesian variable selection. Statistica Sinica 7, 339-374.
[16] George, E.I. (1999). Discussion of Bayesian model averaging and model search
strategies by M.A. Clyde. Bayesian Statistics 6 (J.M. Bernardo, J.O. Berger, A.P.
David and A.F.M. Smith, eds.) Oxford University Press.
[17] Geweke, J. (1996). Variable selection and model comparison in regression. Bayesian
Statistics 5, 609-620.
[18] Lee, K.E., Sha, N., Dougherty, E.R., Vannucci, M., and Mallick, B.K. (2003). Gene
selection: a Bayesian variable selection approach. Bioinformatics 19, 90-97.
[19] Longmate, J.A. (2001). Complexity and power in case-control association studies.
Am J Hum Genet 68, 1229-1237.
[20] McCullagh, P., and Nelder J.A. (1989). Generalized Linear Models. London: Chapman and Hall, 2nd edition.
[21] Mengersen, K.L., Robert, C.P., and Guihenneuc-Jouyaux, C. (1999). MCMC Convergence Diagnostics: A Review. Bayesian Statistics 6, 415-440.
[22] Neter, J., Kutner, M.H., Nachtsheim, C.J., and Wasserman, W. (1996). Applied
linear statistical models. The McGraw-Hill Companies, Inc.
[23] O’Meara, J., Kardia, S. L., Armon, J.J., and Turner, S.T. Prevalence, treatment
and control of dyslipidemia in a hypertensive population. Archives of Internal Med.
Submitted.
23

http://biostats.bepress.com/umichbiostat/paper48

[24] Province, M.A., Kardia, S.L.R., Ranade, K., Rao, D.C., Thiel, B.A., Cooper, R.S.,
Risch, N., Turner, S.T., Cox, D.R., Hunt, S.C., Weder A.B., and Boerwinkle, E.
(2003). A Meta-Analysis of Genome-Wide Linkage Scans for Hypertension: The
National Heart, Lung and Blood Institute Family Blood Pressure Program. The
American Journal of Hypertension 16, 144-147.
[25] Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R.I.,
Gascoyne, R.D., Muller-Hermelink, H.K., Smeland, E.B., Giltnane, J.M., Hurt,
E.M., Zhao, H., Averett, L., Yang, L., Wilson, W.H., Jaffe, E.S., Simon, R., Klausner, R.D., Powell, J., Duffey, P.L., Longo, D.L., Greiner, T.C., Weisenburger, D.D.,
Sanger, W.G., Dave, B.J., Lynch, J.C., Vose, J., Armitage, J.O., Montserrat, E.,
Lopez-Guillermo, A., Grogan, T.M., Miller, T.P., LeBlanc, M., Ott, G., Kvaloy, S.,
Delabie, J., Holte, H., Krajci, P., Stokke, T., Staudt, L.M.;Lymphoma/Leukemia
Molecular Profiling Project (2002). The use of molecular profiling to predict survival
after chemotherapy for diffuse large B cell lymphoma. The New England Journal
of Medicine 346, 1937-1947.
[26] Sha, N., Vannucci, M., Tadesse, M.G., Brown, P.J., Dragoni. I., Davies, N., Roberts,
T.C., Contestabile, A., Salmon, M., Buckley, C., and Falciani, F. (2004). Bayesian
variable selection in multinomial probit models to identify molecular signatures of
disease stage. Biometrics 60, 812-819.
[27] Tanner, M.A. and Wong, W.H. (1987) The calculation of posterior distributions by
data augmentation (with discussion), Journal of the American Statistical Association 82, 528-550.
[28] West, M. (2003) Bayesian factor regression models in the “Large p, Small n”
paradigm. Bayesian Statistics 7, 723-732.
24

Hosted by The Berkeley Electronic Press

0.9
0.7
0.6

mode=0.1, bernoulli, rho=0.3
mode=0.2, bernoulli, rho=0.3
mode=0.1, bernoulli, rho=0.9
mode=0.2, bernoulli, rho=0.9

0.3

0.4

0.5

True positive rate

0.8

0.9
0.8
0.7
0.6

True positive rate

0.3

0.4

0.5

bernoulli, rho=0.3
binomial, rho=0.3
bernoulli, rho=0.9
binomial, rho=0.9

0.00

0.05

0.10

0.15

0.00

0.05

False positive rate

0.10

0.15

False positive rate

(a) Beta-Bernoulli vs. Beta-Binomial

(b) Beta prior(mode,mean): (0.1, 0.12) vs. (0.2,
0.22)

0.8
0.6

True positive rate

rho=0.9,Conditional prior
rho=0.3,Conditional prior
rho=0.9,Unconditional prior
rho=0.3,Unconditional prior

0.2

0.2

0.4

0.6

rho=0.9, Conditional prior
rho=0.3, Conditional prior
rho=0.9, Unconditional prior
rho=0.3, Unconditional prior

0.4

True positive rate

0.8

1.0

1.0

Figure 1. ROC curves of sensitivity analysis with n = 20, p = 50, replicates=250, and number of true
predictors=2. Cutoff points at: 2,4,6,8,10,12,14
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Figure 2. ROC curves for comparing Conditional vs. Unconditional prior with (mode, mean)=(0.12,
0.14), n = 20, main effects=10, interactions=45, and replicates=250.
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Figure 4. The marginal posterior distributions of γ for 579
regressors at stage I. The first 66 are the main effects. The rest
are the interaction terms.
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Table 1. The joint and marginal prior probability for γ
Joint prior probability
ConditionalγA
γB
γAB
BetaBinomial
BetaBinomial
0
0
(1 − w)3
(1 − w)3
0
2
1
0
0
w(1 − w)
w(1 − w)2
2
0
1
0
w(1 − w)
w(1 − w)2
2
0
0
1
w(1 − w)
0
1
1
0
w2 (1 − w)
w2 (1 − w)
1
0
1
w2 (1 − w)
0
0
1
1
w2 (1 − w)
0
1
1
1
w3
w
Marginal
Beta-Binomial
w
w
w
ConditionalPrior
Probability Beta-binomial 1 − (1 − w)2 1 − (1 − w)2
w
−1
w is the mean a(a + b) of the hyperprior Beta distribution

Table 2. ANOVA test of sensitivity
Est. is the true positive rate
Effect
Level
Mean (se)
0.773 (0.213)
Rho
0.1
0.3
0.776 (0.216)
0.5
0.771 (0.213)
0.7
0.756 (0.209)
0.9
0.716 (0.194)
Prior
bernoulli
0.759 (0.208)
binomial
0.758 (0.208)
Hyperprameter (0.1, 0.12) 0.757 (0.208)
(0.2, 0.22)
0.76 (0.208)
Cutoff
2
0.327 (0.003)
4
0.602 (0.017)
6
0.782 (0.038)
8
0.852 (0.034)
10
0.892 (0.029)
12
0.918 (0.023)
14
0.935 (0.020)

p-value

< 0.001
0.793
0.173

< 0.001
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Gene
Name
ALMS1

AUP1
C2ORF6
DQX1
MGC10955
MTHFD2

Table 3. SNP look-up Table
Gene description
Locuslink
ID
Alstrom syndrome 1
7840

SNP

ancient ubiquitous protein 1
chromosome 2
open reading frame 6
DEAQ box polypeptide 1
(RNA-dependent ATPase)
hypothetical protein MGC10955

550
407654

cv11541174, cv167406,
cv221633, cv8884674,
cv9517435
cv11727841
cv1137486

165545

cv2630842

84762

methylene tetrahydrofolate
dehydrogenase (NAD+ dependent),
methenyltetrahydrofolate
cyclohydrolase
solute carrier family 4,
sodium bicarbonate
cotransporter, member 5

10797

cv1137462, cv1137467,
cv1137468
cv339864, cv9517519

protease, serine, 25
sodium channel, voltage-gated,
type VII, alpha
solute carrier family 4, sodium
bicarbonate transporterlike, member 10
WW domain binding protein 1
adducin 2 (beta)

27429
6332

rs4853018, CV1137521,
CV1137522, CV1137528,
CV1137534,CV1137535,
CV1137538, CV1137542,
CV11727981, CV197439
cv2294084
cv2161217, cv356958

57282

cv1300937, cv1300974

23559
119

ADRA2B
ATP6B1

adrenergic, alpha-2B-, receptor
ATPase, H+ transporting,
lysosomal 56/58kDa,
V1 subunit B, isoform 1 (Renal
tubular acidosis with deafness)

151
525

SLC20A1

solute carrier family
20 (phosphate transporter),
member 1

6574

cv2630862
CV11184, CV11464892,
CV2634640, CV2634654,
CV2634655, CV2805331,
CV2805332, CV2805339,
CV9987151
hx2173, hx2767, hx4699
CV2308451, CV2673636,
CV2673637, CV2673638,
CV2673639, rs1024764,
rs1024765, rs2239484,
rs2239487, rs2266917
CV11888001, CV248672,
CV478858, CV9546434,
CV9546587, rs1061254

SLC4A5

PRSS25
SCN7A
SLC4A10

WBP1
ADD2

57835
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Table 4. The partial importance list from stage I for hypertension data
Variable Name
Rank
Marginal
Posterior
Main
All Effect Interaction Probability
age
1
1
.
1
BMI
2
2
.
0.19
systolic BP
3
3
.
0.17
height
4
4
.
0.16
diastolic BP
5
5
.
0.15
triglyceride
6
6
.
0.14
cholesterol
7
7
.
0.11
weight
8
8
.
0.11
strong family history
9
9
.
0.07
SLC20A1 CV478858
10
10
.
0.07
SLC20A1 CV248672
11
11
.
0.07
MGC10955 cv1137467
12
12
.
0.06
BMI × SLC20A1 CV478858
13
.
1
0.06
NBC4 CV1137542
14
13
.
0.06
NBC4 CV11727981
15
14
.
0.06
SLC20A1 CV9546434
16
15
.
0.05
WBP1 cv2630862
17
16
.
0.05
ADD2 CV2805332
18
17
.
0.04
diastolic BP × SLC20A1 CV248672
19
.
2
0.04
SLC20A1 rs1061254
20
18
.
0.04
21
19
.
0.04
DQX1 cv2630842
AUP1 cv11727841
22
20
.
0.04
strong family history × AUP1 cv11727841
25
.
3
0.03
triglyceride × NBC4 CV11727981
28
.
4
0.03
cholesterol× WBP1 cv2630862
31
.
5
0.03
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Table 5. The adjusted R-squares for selected models
Model
Regressors
Covariates
SNPs
Interactions
AUP1 cv11727841,
strong family history
Two Stage ∗
Age,
Bayessian
strong family SLC20A1 CV9546434
× AUP1 cv11727841
history
Variable
AUP1 cv11727841,
strong family history
selection
∗∗
Age,
strong family
× AUP1 cv11727841
history
AUP1 cv11727841,
strong family history
∗ ∗ ∗ Age,
strong family WBP1 cv2630862
× AUP1 cv11727841,
history,
cholesterol ×
WBP1 cv2630862
cholesterol
Two stage
Age,
ALMS1 cv167406,
Age ×
strong family MGC10955 cv1137467, SLC20A1 CV9546434
stepwise
selection
ADD2 CV2805339,
history
SLC20A1 CV9546434
∗ The model with the highest joint posterior probability in Stage II.
∗∗ The model with the second highest joint posterior probability in Stage II.
∗ ∗ ∗ The model with the second highest joint posterior probability in Stage II.

Variable
intercept
age
strong family history
AUP1 cv11727841

Table 6. Parameter Estimates
Est. (se)
-5.32 (5.50)
0.59 (0.05)
18.95 (9.96)

AA
AC
CC
SLC20A1 CV9546434
AA
AG
GG
strong family history × AUP1 cv11727841
AA
AC
CC

Adj.
Rsq.
0.3161

0.2898

0.3022

0.3191

p-value
0.3342
< .0001
0.0580

9.69 (3.84)
6.88 (3.95)
reference

0.0120
0.0823
-

9.96 (2.84)
7.69 (2.93)
reference

0.0005
0.0091
-

-23.49 (10.04)
-16.72 (10.15)
reference

0.0199
0.1005
-
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